Filing Details
- Accession Number:
- 0000914062-11-000313
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-15 18:06:58
- Reporting Period:
- 2011-07-13
- Filing Date:
- 2011-07-15
- Accepted Time:
- 2011-07-15 17:06:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1054701 | B Gerald Seery | Cryolife 1655 Roberts Boulevard, Nw Kennesaw GA 30144 | Sr. Vp, Sales And Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-07-13 | 300 | $4.25 | 58,483 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-07-13 | 300 | $6.00 | 58,183 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-07-14 | 101 | $4.25 | 58,284 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-07-14 | 101 | $6.00 | 58,183 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2011-07-13 | 300 | $0.00 | 300 | $4.25 |
Common Stock | Stock Option | Disposition | 2011-07-14 | 101 | $0.00 | 101 | $4.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,200 | 2007-02-21 | 2011-08-21 | No | 4 | M | Direct |
21,099 | 2007-02-21 | 2011-08-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2011.
- Stock option vested in 20% increments beginning on the first anniversary of the February 21, 2006 grant date.